Search Results - "Ueyama, Azumi"
-
1
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer
Published in Scientific reports (30-03-2022)“…Regulatory T cells (Tregs) suppress the host immune response and maintain immune homeostasis. Tregs also promote cancer progression and are involved in…”
Get full text
Journal Article -
2
Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis
Published in PloS one (06-08-2024)“…Inhibiting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4)-mediated immune checkpoint system using an anti-CTLA-4 antibody (Ab) can suppress the…”
Get full text
Journal Article -
3
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Published in European journal of pharmacology (20-08-2008)“…Pirfenidone, a broad-spectrum antifibrotic agent, is known to have efficacy in certain fibrotic disease models, and is under clinical trials in patients with…”
Get full text
Journal Article -
4
Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod
Published in Journal of dermatology (01-02-2014)“…Topical application of imiquimod (IMQ), a Toll‐like receptor (TLR)7 ligand, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder. In a…”
Get full text
Journal Article -
5
In situ analysis of CCR8 + regulatory T cells in lung cancer: suppression of GzmB + CD8 + T cells and prognostic marker implications
Published in BMC cancer (23-05-2024)“…CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity. This…”
Get full text
Journal Article -
6
A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations
Published in Journal of dermatological science (01-03-2019)“…•We evaluated the anti-psoriatic potential of our novel RORγt inhibitor, S18-000003.•Topical S18-000003 showed strong efficacy in a mouse model of…”
Get full text
Journal Article -
7
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway
Published in Journal for immunotherapy of cancer (15-04-2024)“…BackgroundCancer immunotherapy including immune checkpoint inhibitors is only effective for a limited population of patients with cancer. Therefore, the…”
Get full text
Journal Article -
8
Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model
Published in Journal of dermatological science (01-01-2017)“…Highlights • We examined cell populations involved in skin inflammation in K15.Stat3C mice. • Heterogeneous cell subsets produced IL-17 in TPA-treated…”
Get full text
Journal Article -
9
Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile
Published in The Journal of immunology (1950) (15-08-2023)“…Regulatory T cells (Tregs) contribute to the formation of a tumor-immunosuppressive microenvironment. CCR8 is reportedly selectively expressed in tumor Tregs,…”
Get full text
Journal Article -
10
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
Published in Proceedings of the National Academy of Sciences - PNAS (15-02-2022)“…Foxp3-expressing CD25 CD4 regulatory T cells (Tregs) are abundant in tumor tissues. Here, hypothesizing that tumor Tregs would clonally expand after they are…”
Get full text
Journal Article -
11
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer
Published in Cancer Immunology, Immunotherapy (01-01-2023)“…Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. Since clinical benefits are limited to a subset of patients, we aimed to…”
Get full text
Journal Article -
12
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells
Published in Molecular cancer therapeutics (05-09-2023)“…Abstract Although regulatory T cells (Treg) are inhibitory immune cells that are essential for maintaining immune homeostasis, Tregs that infiltrate tumor…”
Get full text
Journal Article -
13
Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003
Published in Bioorganic & medicinal chemistry letters (01-12-2018)“…[Display omitted] •Highly potent RORγt inhibitors discovered by a precise SAR study.•Detailed binding mode discussion of the compound guided by X-ray cocrystal…”
Get full text
Journal Article -
14
Tumor-infiltrating ICOS + Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor
Published in Anticancer research (01-05-2022)“…Tumor immunity in the tumor microenvironment is activated in patients with feasible clinical responses to immune checkpoint inhibitors. The immunological…”
Get full text
Journal Article -
15
S-531011, a novel anti-human CCR8 antibody, induces potent anti-tumor responses through depletion of tumor-infiltrating CCR8-expressing regulatory T cells
Published in Molecular cancer therapeutics (06-07-2023)“…While regulatory T cells (Tregs) are inhibitory immune cells that are essential for maintaining immune homeostasis, Tregs that infiltrate tumor tissue promote…”
Get full text
Journal Article -
16
Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis
Published in NAR cancer (01-06-2024)“…DNA methylation is a pivotal epigenetic modification that defines cellular identity. While cell deconvolution utilizing this information is considered useful…”
Get full text
Journal Article